Generation Bio/GBIO

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX

About Generation Bio

Generation Bio Co. is a biotechnology company. The Company is innovating non-viral genetic medicines to provide durable, redosable treatments for hundreds of millions of patients living with rare and prevalent diseases. The Company is developing two distinct and complementary platforms: a potent, highly selective cell-targeted lipid nanoparticle (ctLNP) delivery system and a novel immune-quiet DNA (iqDNA) cargo produced by a scalable capsid-free manufacturing process that uses proprietary cell-free rapid enzymatic synthesis (RES). The Company is advancing a portfolio of programs guided by the potent and highly selective delivery of messenger ribonucleic acid (mRNA) and/or iqDNA using its ctLNP delivery system to target T cells, hematopoietic stem cells (HSCs), and hepatocytes, and intend to expand to additional tissues and cell types. Its work in T cells focuses on in vivo reprogramming of this cell type to treat cancer and autoimmune diseases.

Ticker

GBIO

Sector

Healthcare

Trading on

NASDAQ

Industry

Biotechnology & Drugs

CEO

Cameron Mcdonough

Employees

174

Headquarters

Cambridge, United States

Generation Bio Metrics

BasicAdvanced
$212M
Market cap
-
P/E ratio
-$2.56
EPS
2.87
Beta
-
Dividend rate
$212M
2.87
$6.98
$0.86
225K
8.013
-47.14%
-82.24%
-50.75%
21.235
1.602
1.603
-12.44%

What the Analysts think about Generation Bio

Analyst Ratings

Majority rating from 7 analysts.
Buy

Generation Bio Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
-1,862.50% profit margin
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$4M
42.86%
Net income
-$75M
112.25%
Profit margin
-1,862.50%
48.58%

Generation Bio Earnings Performance

Earnings per share (EPS)

Company profitability
Missed by 174.41%
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
-$0.47
-$0.43
-$0.53
-$1.12
-
Expected
-$0.50
-$0.51
-$0.45
-$0.41
-$0.28
Surprise
-5.40%
-14.85%
18.15%
174.41%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. Fundamental data, financials and analyst ratings are sourced from Refinitiv.
Market openNon-fractional

Upcoming events

No upcoming events

FAQs

What’s the current market cap for Generation Bio stock?

Generation Bio (GBIO) has a market cap of $212M as of June 20, 2024.

What is the P/E ratio for Generation Bio stock?

The price to earnings (P/E) ratio for Generation Bio (GBIO) stock is 0 as of June 20, 2024.

Does Generation Bio stock pay dividends?

No, Generation Bio (GBIO) stock does not pay dividends to its shareholders as of June 20, 2024.

When is the next Generation Bio dividend payment date?

Generation Bio (GBIO) stock does not pay dividends to its shareholders.

What is the beta indicator for Generation Bio?

Generation Bio (GBIO) has a beta rating of 2.87. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.

What is the Generation Bio stock price target?

The target price for Generation Bio (GBIO) stock is $7.5, which is NaN% below the current price of $. This is an average based on projections from 4 analysts, and represents their view of what the stock price could be in 12 or 18 months. This should not be seen as investment advice - Lightyear does not carry out investment research.

Buy or sell Generation Bio stock

Buy or sell Generation Bio stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing